These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 10439174)
21. Regional cerebral blood flow imaging: a quantitative comparison of technetium-99m-HMPAO SPECT with C15O2 PET. Gemmell HG; Evans NT; Besson JA; Roeda D; Davidson J; Dodd MG; Sharp PF; Smith FW; Crawford JR; Newton RH J Nucl Med; 1990 Oct; 31(10):1595-600. PubMed ID: 2120397 [TBL] [Abstract][Full Text] [Related]
22. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment. Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707 [TBL] [Abstract][Full Text] [Related]
23. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO). Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154 [TBL] [Abstract][Full Text] [Related]
24. Comparison between cortical distribution of I-123 iomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT. Varrone A; Soricelli A; Postiglione A; Salvatore M Clin Nucl Med; 1999 Sep; 24(9):660-5. PubMed ID: 10478740 [TBL] [Abstract][Full Text] [Related]
25. SPECT brain perfusion abnormalities in mild or moderate traumatic brain injury. Abdel-Dayem HM; Abu-Judeh H; Kumar M; Atay S; Naddaf S; El-Zeftawy H; Luo JQ Clin Nucl Med; 1998 May; 23(5):309-17. PubMed ID: 9596157 [TBL] [Abstract][Full Text] [Related]
26. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment. Derejko M; Sławek J; Wieczorek D; Brockhuis B; Dubaniewicz M; Lass P Nucl Med Commun; 2006 Dec; 27(12):945-51. PubMed ID: 17088679 [TBL] [Abstract][Full Text] [Related]
27. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. O'Brien JT; Eagger S; Syed GM; Sahakian BJ; Levy R J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1182-7. PubMed ID: 1479398 [TBL] [Abstract][Full Text] [Related]
29. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria. Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634 [TBL] [Abstract][Full Text] [Related]
30. Neurospect in neurotoxic chemical exposure demonstration of long-term functional abnormalities. Heuser G; Mena I Toxicol Ind Health; 1998; 14(6):813-27. PubMed ID: 9891913 [TBL] [Abstract][Full Text] [Related]
31. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease. Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226 [TBL] [Abstract][Full Text] [Related]
32. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors. Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621 [TBL] [Abstract][Full Text] [Related]
33. Vascular cognitive impairment in small vessel disease: clinical and neuropsychological features of lacunar state and Binswanger's disease. Ramos-Estebanez C; Moral-Arce I; Gonzalez-Mandly A; Dhagubatti V; Gonzalez-Macias J; Munoz R; Hernadez-Hernandez JL Age Ageing; 2011 Mar; 40(2):175-80. PubMed ID: 21239411 [TBL] [Abstract][Full Text] [Related]